Metropolitan Life Insurance Company (MetLife)’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,900
| Closed | -$604K | – | 2605 |
|
|
2019
Q3 | $604K | Buy |
8,900
+1,613
| +22% | +$111K | 0.01% | 1181 |
|
|
2019
Q2 | $424K | Buy |
7,287
+526
| +8% | +$31.2K | 0.01% | 1410 |
|
|
2019
Q1 | $474K | Sell |
6,761
-199
| -3% | -$14.8K | 0.01% | 1338 |
|
|
2018
Q4 | $448K | Hold |
6,960
| – | – | 0.01% | 1259 |
|
|
2018
Q3 | $489K | Hold |
6,960
| – | – | 0.01% | 1365 |
|
|
2018
Q2 | $351K | Hold |
6,960
| – | – | 0.01% | 1554 |
|
|
2018
Q1 | $218K | Hold |
6,960
| – | – | ﹤0.01% | 1842 |
|
|
2017
Q4 | $238K | Sell |
6,960
-6,282
| -47% | -$200K | ﹤0.01% | 1799 |
|
|
2017
Q3 | $425K | Hold |
13,242
| – | – | ﹤0.01% | 1795 |
|
|
2017
Q2 | $431K | Hold |
13,242
| – | – | ﹤0.01% | 1810 |
|
|
2017
Q1 | $417K | Hold |
13,242
| – | – | ﹤0.01% | 1782 |
|
|
2016
Q4 | $389K | Hold |
13,242
| – | – | ﹤0.01% | 1898 |
|
|
2016
Q3 | $383K | Hold |
13,242
| – | – | ﹤0.01% | 1874 |
|
|
2016
Q2 | $343K | Hold |
13,242
| – | – | ﹤0.01% | 1935 |
|
|
2016
Q1 | $328K | Hold |
13,242
| – | – | ﹤0.01% | 1841 |
|
|
2015
Q4 | $466K | Hold |
13,242
| – | – | ﹤0.01% | 1662 |
|
|
2015
Q3 | $280K | Hold |
13,242
| – | – | ﹤0.01% | 2025 |
|
|
2015
Q2 | $368K | Sell |
13,242
-757
| -5% | -$21.4K | ﹤0.01% | 1965 |
|
|
2015
Q1 | $428K | Hold |
13,999
| – | – | ﹤0.01% | 1635 |
|
|
2014
Q4 | $448K | Hold |
13,999
| – | – | ﹤0.01% | 1837 |
|
|
2014
Q3 | $396K | Hold |
13,999
| – | – | ﹤0.01% | 1869 |
|
|
2014
Q2 | $384K | Hold |
13,999
| – | – | ﹤0.01% | 2031 |
|
|
2014
Q1 | $369K | Hold |
13,999
| – | – | ﹤0.01% | 2014 |
|
|
2013
Q4 | $410K | Hold |
13,999
| – | – | ﹤0.01% | 1942 |
|
|
2013
Q3 | $428K | Hold |
13,999
| – | – | ﹤0.01% | 1855 |
|
|
2013
Q2 | $444K | Buy |
+13,999
| New | +$460K | ﹤0.01% | 1769 |
|
Metropolitan Life Insurance Company (MetLife)'s GHDX Position: Q4 2019 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 8,900 shares — an estimated $604K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $604K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 8,900 Genomic Health, Inc. shares in Q4 2019, an estimated $604K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Genomic Health, Inc. position peaked at $604K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2019, filed 14 Feb 2020.